Observational studyJournal of patient-reported outcomes2025

Improved quality of life in cystic fibrosis patients observed up to 36 months after starting Elexacaftor/Tezacaftor/Ivacaftor treatment.

Francesca Buniotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.